The «Center for innovative vaccines», the only one in Central Asia, will be established in Uzbekistan

Project cost - $100 million. The center produces 10 different vaccines against hepatitis A-B, papilloma, measles, tetanus and other diseases worth $2 ml per year.

Within the framework of the SCO summit of heads of state, the Minister of Innovative Development Ibrahim Abdurakhmanov and Luye Invetment Group Co. An online meeting was held between the head of the Company Ltd. In it, the Ministry of innovative development cooperates with the company for the period 2023-2028 with a total value of 100 million rubles. a Memorandum was signed on the establishment of the Center for innovative vaccines, equivalent to the dollar.

"Center for innovative vaccines" is the only full-cycle biotechnological development enterprise in Central Asia, which makes it possible to provide the market of domestic and CIS countries with high-tech products.

Considering the scientific volume of this full-cycle biotechnological production enterprise and the involvement of highly qualified scientific specialists in the future, it is proposed to organize the “Center for innovative vaccines" in the Tashkent region.